Picture of Onconetix logo

ONCO — Onconetix News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Brief: Blue Water Biotech Issues Shareholder Letter Providing Update On Commercial Launch Activities

July 17 (Reuters) - Blue Water Biotech Inc  BWV.O :
    * BLUE WATER BIOTECH ISSUES CEO SHAREHOLDER LETTER PROVIDING
UPDATE ON COMMERCIAL LAUNCH ACTIVITIES
    * BLUE WATER BIOTECH INC - IN PROCESS OF IDENTIFYING RIGHT
TELEMEDICINE PARTNER FOR ENTADFI AND POTENTIALLY OTHER ASSETS IN
OUR PORTFOLIO
    * BLUE WATER BIOTECH INC - RECENTLY SIGNED AN AGREEMENT WITH
ADVANTAGE POINT SOLUTIONS, LLC
    * BLUE WATER BIOTECH- DEAL WITH ADVANTAGE POINT SOLUTIONS TO
ASSIST FORMULARY NEGOTIATIONS WITH HEALTHCARE PAYERS,PHARMACY
BENEFIT MANAGERS FOR ENTADFI

Source text for Eikon:  ID:nGNX2M0mz9 
Further company coverage:  BWV.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Onconetix

See all news